209 related articles for article (PubMed ID: 2481793)
21. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.
Wallgren A; Festin R; Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
Blood; 1993 Aug; 82(4):1230-8. PubMed ID: 8102559
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
Tangye SG; Weston KM; Raison RL
Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
24. Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets.
Beiske K; Clark EA; Holte H; Ledbetter JA; Smeland EB; Godal T
Int J Cancer; 1988 Oct; 42(4):521-8. PubMed ID: 2459071
[TBL] [Abstract][Full Text] [Related]
25. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.
Trentin L; Zambello R; Agostini C; Siviero F; Adami F; Marcolongo R; Raimondi R; Chisesi T; Pizzolo G; Semenzato G
Blood; 1993 Feb; 81(3):752-8. PubMed ID: 8381309
[TBL] [Abstract][Full Text] [Related]
26. B8.7 antigen expression on B-CLL cells and its relationship to the LMW-BCGF responsiveness.
Karray S; Leprince C; Merle-Beral H; Debre P; Richard Y; Galanaud P
Leuk Res; 1990; 14(9):809-14. PubMed ID: 2232853
[TBL] [Abstract][Full Text] [Related]
27. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
Engel P; Inglés J; de la Calle O; Gallart T
Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
[TBL] [Abstract][Full Text] [Related]
28. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.
Foa R; Massaia M; Cardona S; Tos AG; Bianchi A; Attisano C; Guarini A; di Celle PF; Fierro MT
Blood; 1990 Jul; 76(2):393-400. PubMed ID: 2114936
[TBL] [Abstract][Full Text] [Related]
29. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis.The Tampere Chronic Lympocytic Leukemia group.
Larramendy ML; Siitonen SM; Zhu Y; Hurme M; Vilpo L; Vilpo JA; Knuutila S
Cytogenet Cell Genet; 1998; 82(3-4):215-21. PubMed ID: 9858820
[TBL] [Abstract][Full Text] [Related]
30. The response of human B cells to interleukin 4 is determined by their stage of activation and differentiation.
Maher DW; Pike BL; Boyd AW
Scand J Immunol; 1990 Dec; 32(6):631-40. PubMed ID: 1702898
[TBL] [Abstract][Full Text] [Related]
31. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
32. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
33. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
34. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
[TBL] [Abstract][Full Text] [Related]
35. Response patterns of hairy cell leukemia to B-cell mitogens and growth factors.
Barut BA; Cochran MK; O'Hara C; Anderson KC
Blood; 1990 Nov; 76(10):2091-7. PubMed ID: 2242429
[TBL] [Abstract][Full Text] [Related]
36. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.
di Celle PF; Carbone A; Marchis D; Zhou D; Sozzani S; Zupo S; Pini M; Mantovani A; Foa R
Blood; 1994 Jul; 84(1):220-8. PubMed ID: 7517209
[TBL] [Abstract][Full Text] [Related]
37. Differential response of malignant human B-cells to anti-IgM immunoglobulin (anti-mu) and B-cell growth factor: unique direct cytotoxicity of anti-mu on prolymphocytic leukemia cells.
Chan CS; Soehnlen F; Schechter GP
Blood; 1990 Oct; 76(8):1601-6. PubMed ID: 2119832
[TBL] [Abstract][Full Text] [Related]
38. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.
Perri RT
Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460
[TBL] [Abstract][Full Text] [Related]
39. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia.
Sarfati M; Fournier S; Christoffersen M; Biron G
Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
